Industry should improve the standards on application of risk management tools in light of the cases of nitrosamine impurities.
Stephanie Snow
Advertisement
Stephanie Snow is CMC manager at Kinapse Ltd, UK.
Articles by Stephanie Snow
Advertisement
Latest Updated Articles
Nitrosamine Impurities in Medicinal ProductsPublished: December 3rd 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
2
PharmTech Weekly News Roundup – Week of November 3, 2025
3
AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies
4
2025 AAPS PharmSci 360 to Highlight Next-Gen AI for Drug Development
5
